Active Ingredient(s):Methsuximide FDA Approved: * February 8, 1957 Pharm Company: *PARKE DAVIS Category:Anticonvulsant
Mesuximide (or methsuximide, methosuximide) is a succinimide anticonvulsant medication. It is sold as a racemate by Pfizer under the tradenames Petinutin (Switzerland) and Celontin (United States). The therapeutic efficacy of methosuximide is largely due to its pharmacologically active metabolite, N-desmethylmethosuximide, which has a longer half-life and attains much higher plasma levels than its parent.
is indicated for...
* May have multiple approval dates, manufacturers, or labelers.